Atlas Laboratories and Pharmaceuticals Ltd (ALPL), a division of bicycle manufacturers Atlas, has finally launched a range of pharmaceutical products in Jammu and Kashmir.

Drugmaker Cadila Healthcare Ltd announced that it has acquired a majority

Sun Pharma, India's largest pharmaceutical company by market capitalisation, has failed to clinch the deal for Israeli major Taro Pharma.

Dr Reddy's Laboratories, one of the leading Indian pharmaceutical companies, has launched Atocor-R (Atorvastatin + Ramipril) in Indian market.

Leading drugmaker Lupin announced that it has received tentative

Zydus Cadila, India’s fourth largest pharmaceutical group and a global healthcare provider announced that it has acquired 100% stake in a Spain’s Laboratorios Combix to gain entry into the Spainsh market.

Laboratorios Combix, which has a pure generic focus, provides the right fit for Zydus’ entry strategy into a market that is estimated at USD 1.7 billion and is growing at 21.5%, as against 6% for the overall pharmaceutical market in 2007.

Established in 2006, Combix with a sales and marketing focus has a solid portfolio covering 17 molecules.